CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

東京医科大学（学長：宮澤啓介／東京都新宿区）の医学科6年 永松由衣、分子病理学分野 梅津知宏 講師、黒田雅彦 主任教授らの研究チームは、AMEDの創薬研究開発プログラムの支援を得てアセロラ由来のエクソソーム様ナノ小胞（acerola-derived exosome-like nanovesicles：AELNs*）を用いた CRISPR/Cas9 ゲノム編集因子の脳内送達技術を開発しました。本研究 ...

DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

テルアビブ大学の研究者らが、CRISPR-Cas9遺伝子編集技術を用いてマウスの頭にある腫瘍を半分除去することに成功したと ...

Dr Annarita Miccio told the ELRIG meeting in March 2026 that gene therapy for sickle cell disease and beta-thalassaemia has ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its ...

A US patent board last week backed the Broad Institute’s claim to CRISPR use in human and animal cells, not the Nobel winners ...

If you are wondering whether CRISPR Therapeutics at around US$48.75 is a bargain or a concern, the key question is how its current share price lines up with what the business may be worth. The stock ...